Select for export A single dose of psilocybin alleviates chronic pain and associated anxiety and depression in mice Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1036/1097-8542.br2511031 Copy citation Copy BibTeX Unknown journal 2025-11-05 AccessScience Editors OpenAlex Published psilocybin DepressionAnxietyChronic Pain Animal Study More
Select for export Divergent effects of ketamine and psilocybin on EEG power spectral density in a mismatch negativity paradigm No abstract availability was recorded for this entry. Details DOI 10.5167/uzh-292276 Copy citation Copy BibTeX Universität Zürich, ZORA 2025-11-04 Milad Soltanzadeh, Zheng Wang, Shona G. Allohverdi, Colleen E. Charlton, André Schmidt, Franz Xaver Vollenweider OpenAlex Published psilocybin DepressionAnxietyBrain Imaging Other More
Select for export Classic psychedelics may treat depressive disorders, but more evidence and legislative changes are required No abstract availability was recorded for this entry. Details DOI 10.1007/s40267-025-01199-5 Copy citation Copy BibTeX Drugs & Therapy Perspectives 2025-11-04 Aisling McGuigan OpenAlex Published psilocybin DepressionAddictionChronic Pain Randomized Controlled Trial More
Select for export Psilocybin - Induced Neuroplasticity in the Treatment of Major Depressive Disorder Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-04 Yale University ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionNeuroplasticity Other More
Select for export A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-11-04 University of Washington ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAnxietyReceptor Pharmacology Clinical Trial More
Select for export Psilocybin reduces depressive-like behavior and improves cognition in healthy aging mice via epigenetic regulation of plasticity- and immune-related genes Abstract available at the source but not redistributed here. Read at source. Details DOI 10.21203/rs.3.rs-7890051/v1 Copy citation Copy BibTeX Research Square 2025-11-04 Mennenga S, Hanson T, Semple M, Lifshitz D, Flores B, Balducci J Europe PMC PREPRINT (not peer reviewed) psilocybin DepressionNeuroplasticityMechanism of Action Animal Study More
Select for export Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted Therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/psychoactives4040039 Copy citation Copy BibTeX Psychoactives 2025-11-01 Faith Ekoh, Shanice Rerrie, James Angud, Ersilia Mirabelli OpenAlex Published psilocybin DepressionAddictionNeuroplasticity Review Article More
Select for export Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.addbeh.2026.108652 Copy citation Copy BibTeX PsyArXiv 2025-11-01 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionObservational Study Observational Study More
Select for export Psilocybin bei Alkoholkonsumstörung Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-2702-9616 Copy citation Copy BibTeX Suchttherapie 2025-10-31 Authors unavailable OpenAlex Published psilocybin DepressionAddictionPharmacology Other More
Select for export Metaanalyse: Wirksamkeit und Sicherheit von Psilocybin bei Major Depressionen Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1055/a-2576-6069 Copy citation Copy BibTeX Fortschritte der Neurologie · Psychiatrie 2025-10-31 Authors unavailable OpenAlex Published psilocybin DepressionToxicity Other More
Select for export Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.peh.2025.100386 Copy citation Copy BibTeX Performance Enhancement & Health 2025-10-31 Thomas Zandonai, Sofia Venturini, Ornella Corazza OpenAlex Published psilocybin DepressionAddictionChronic Pain Other More
Select for export The emotional architecture of the psychedelic brain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.tics.2025.07.006 PubMed 40830011 Copy citation Copy BibTeX Trends in cognitive sciences 2025-10-31 Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH PubMed Published psilocybin DepressionChronic PainNeuroplasticity Review Article More
Select for export The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pbb.2025.174087 PubMed 40849009 Copy citation Copy BibTeX Pharmacology, biochemistry, and behavior 2025-10-31 Rahmani S, Crupi R, Riley AL, Davidson T PubMed Published psilocybin DepressionAnxietyPTSD Other More
Select for export Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjo.2025.10847 PubMed 41178084 Copy citation Copy BibTeX BJPsych Open 2025-10-31 Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi OpenAlex Published psilocybin DepressionAnxietyPTSD Randomized Controlled Trial More
Select for export “It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00220426251395178 Copy citation Copy BibTeX Journal of Drug Issues 2025-10-30 Blake Beaton OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03654-3 PubMed 41173871 Copy citation Copy BibTeX Unknown journal 2025-10-30 d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Systematic Review More
Select for export Psilocybin use in bipolar disorder: A comprehensive review. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.jad.2025.120485 PubMed 41177271 Copy citation Copy BibTeX Unknown journal 2025-10-30 Do A, Cloutier L, Hébert-Tremblay L, Thauvin C. Europe PMC Published psilocybin DepressionAnxietyAddiction Clinical Trial More
Select for export A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-29 Ohio State University ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export Psilocybin as a fast-acting and long-lasting antidepressant for adolescence: Proposing NeuroD1 as a biomarker of its long-term plasticity Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.biopha.2025.118720 PubMed 41172953 Copy citation Copy BibTeX Biomedicine & Pharmacotherapy 2025-10-29 Rubén García-Cabrerizo, Itziar Beruete-Fresnillo, Pedro Bergas-Cladera, M. Julia García-Fuster OpenAlex Published psilocybin DepressionNeuroplasticityNeurogenesis Observational Study More
Select for export A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-28 Anna Rose Childress, Ph.D. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAddictionOCD Clinical Trial More
